Pharmaceuticals · Department Head · Long Time No Contact
Introduction for Pharmaceuticals Department Head: Long Time…
A introduction email for a Pharmaceuticals Department Head (long time no contact) is a short message that reopens the thread without making them do extra work. An introduction email explains who you are, why this person should care, and what a good next step looks like, without making them do the homework. In this setting, that means speaking to follow-up
Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors
We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.
Sources: HubSpot sales email benchmarks; Gong follow-up research
Why does this introduction work for a Pharmaceuticals Department Head?
- Lead with the overlap, not your résumé.
- Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
- Fits how a department head actually reads: Give enough context that they can forward the email upward.
- Bring a new observation about their world, then offer a small, optional next step.
- Make it easy to decline.
When should I send this to a Pharmaceuticals Department Head?
If a mutual offered the intro, send it while their permission is fresh. Send when you have a real trigger: news, a useful artifact, a role change, a season. For this combo, treat "Only when you have a trigger" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a department head, Give enough context that they can forward the email upward.
What this Department Head actually cares about
A department head in Pharmaceuticals is protecting their team's load and their standing with leadership. They sit between strategy and the people doing the work. They need cover to say yes and a way to not look reckless. The hook that earns a look is a department KPI, a staffing bind, or a tool the team already hates. The ask should stay at this size: a working review they can invite a deputy to. Delete trigger: Going over their head in the same thread. If your note would embarrass them in a team channel, rewrite it.
How Pharmaceuticals changes the note
Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. A thread that ignores follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick reads like every other vendor bump.
How should I customize this template before I send it?
- Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
- Keep the tone respectful of internal politics without being coy.
- Keep titles accurate. Inflating your role gets checked.
- Time it for Only when you have a trigger. Send when you have a real trigger: news, a useful artifact, a role change, a season.
- Don't use consumer-startup slang. It's a credibility leak.
What mistakes should I avoid with this long time no contact note?
- Giant bios make intros feel like homework.
- Don't open with 'it's been a while' and then paste the old pitch.
- Don't use consumer-startup slang. It's a credibility leak.
- Going over their head in the same thread.
How does this long time no contact scenario compare?
| Dimension | For this template |
|---|---|
| Best send window | Only when you have a trigger |
| Ideal length | Give enough context that they can forward the email upward. |
| Primary ask | a working review they can invite a deputy to |
| Industry metric to cite | time through MLR, access, and compliant engagement rates |
| Tone | Respectful of internal politics without being coy. |
| Unlike no response | This isn't a 4-day bump. It's a re-introduction with a new reason. |
| Unlike breakup | You're opening a door, not closing one. Still keep it easy to ignore. |
What should I copy and send?
Copy-ready template
Subject
[Company Name] / time through MLR
Body
Hi [First Name], I'm reaching out because [specific overlap], not because I collect new LinkedIn contacts. In Pharmaceuticals, that usually shows up as follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick. I help [type of company] with cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Recent example: [result] for [similar team]. If that's irrelevant, ignore this. Given this is long time no contact, ask if the old problem still exists, or if you should leave it archived. No pressure either way. I know unsolicited intros can be noise. Best, [Your Name] [Your Title] [Your Company]
Questions people ask before they hit send
Yes. Many won't champion something they can't explain in one skim. Write a paragraph their VP could understand without a briefing. That's often the real audience even when their name is on the To line. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.
Related templates
Introduction for Pharmaceuticals Team Lead (Long Time No Contact)
Introduction for SaaS Department Head (Long Time No Contact)
Referral Request for Pharmaceuticals Department Head (Long Time No Contact)
Introduction for Pharmaceuticals Department Head (No Response)
Introduction for Pharmaceuticals Department Head (Replied Then Silent)
Want a custom draft instead? Try the email generator.